More frequent manic/mixed and depressive episodes were associated with an increased risk for Parkinson disease.
Parkinsonism is a lesser known debilitating adverse effect associated with valproate, especially in older patients.
There were no significant differences between pimavanserin and quetiapine in time to discontinuation, mortality, or improvement in psychosis in patients with Parkinson disease and Lewy body dementia.
Multiple genetic risk loci for Alzheimer disease predict longitudinal cognitive decline in patients with Parkinson disease without dementia.
Mindfulness yoga is a safe and effective treatment option for patients with mild-to-moderate Parkinson disease to help them manage stress and symptoms.
Motor complications are associated with suicidal ideation in Parkinson disease.
Kyowa Hakko Kirin announced that the FDA has accepted the resubmitted NDA for istradefylline for use as adjunctive treatment to levodopa/carbidopa in adults with Parkinson disease experiencing OFF episodes.
Federal government has received high number of reports about deaths among patients taking Nuplazid
The integration of technology into medicine has expanded into various uses in patients with Parkinson disease.
Researchers have proposed a model that can explain the degree of depression in Parkinson disease, using imaging and genetics data.